How Pfizer Won The Pandemic, Reaping Outsize Profit And Influence
Pfizer's success in developing COVID medicines has given the drugmaker unusual weight in determining U.S. health policy.
Pfizer's success in developing COVID medicines has given the drugmaker unusual weight in determining U.S. health policy.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Concerns linger as state health officials start to distribute funds lawmakers authorized in 2021.
The World Health Organization's estimate is more than double the current official death toll of over 6 million.
A long-standing paramedic shortage has been exacerbated by turnover and resignations related to pandemic burnout.
Some children wait more than a year after diagnosis to begin behavioral therapy, but research shows early treatment can be crucial.
Portland psychologist Doreen Dodgen-Magee, author of the book “Restart - Designing a Healthy Post Pandemic Life,” says flexibility is key.
Some people with disabilities have been left behind even as telemedicine, teleworking, rapid tests, virtual school, and vaccine drive-thrus have become part of most Americans’ pandemic routines.
With millions of people nationally losing their Medicaid benefits when the pandemic health emergency ends, some may sign up for different insurance, while others are expected to get lost in the transition.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
As the COVID-19 pandemic nears the two-year mark, state legislators say its lessons are spawning bills.
America’s hospitals, strained by nearly two years of fighting the COVID-19 pandemic, are now scrounging for basic medical supplies.